Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Exam (elaborations)

PHAR 515 Final Exam Study Guide (2026) | 350+ Practice Questions & Verified Answers | Pharmacoeconomics, Drug Approval Process, Clinical Trials, Professionalism & Community Pharmacy

Rating
-
Sold
-
Pages
33
Grade
A+
Uploaded on
01-07-2026
Written in
2025/2026

Prepare for the PHAR 515 Final Exam with this comprehensive 2026 study guide, featuring 350+ exam-style practice questions with verified answers and detailed rationales covering the essential principles of pharmacoeconomics, patient-reported outcomes (PROs), drug development and FDA approval, clinical research, pharmacy law, professionalism, community pharmacy practice, opioid policy, COVID-19 diagnostics, and geriatric pharmacy. Designed for pharmacy students, this resource strengthens evidence-based clinical decision-making, regulatory knowledge, healthcare policy understanding, and pharmacy practice competencies while preparing learners for final examinations, licensure readiness, and professional practice. The practice questions closely reflect the structure and complexity of PHAR 515 assessments, making this an essential review guide for pharmacy education. This study guide provides comprehensive coverage of pharmacoeconomics and health outcomes research, including patient-reported outcomes (PROs), clinical outcomes, clinician-reported outcomes, economic outcomes, humanistic outcomes, health-related quality of life (HRQOL), quality-adjusted life years (QALYs), health state utilities, direct medical costs, direct non-medical costs, indirect costs, intangible costs, cost-effectiveness analysis, comparative effectiveness research, quality-of-life instruments, disease-specific outcome measures, healthcare decision-making, and value-based pharmaceutical care. It also delivers an in-depth review of the drug discovery and FDA approval process, including drug discovery, preclinical testing, Investigational New Drug (IND) applications, Phase I, II, and III clinical trials, New Drug Applications (NDA), Abbreviated New Drug Applications (ANDA), generic drug approval, post-marketing surveillance, FDA Adverse Event Reporting System (FAERS), MedWatch, bioavailability, bioequivalence, randomized controlled trials (RCTs), placebo-controlled studies, randomization methods, blinding techniques, comparative effectiveness trials, clinical research methodology, and evidence-based pharmaceutical evaluation. Every verified answer reinforces critical concepts required for pharmacy examinations and clinical practice. The guide also offers extensive review of professional pharmacy practice, healthcare law, and contemporary pharmacy services, including professionalism, pharmacist responsibilities, delegation to pharmacy technicians, HIPAA, Protected Health Information (PHI), pharmacy ethics, patient counseling, collaborative practice agreements (CPAs), statewide protocols, Medication Therapy Management (MTM), telepharmacy, pharmacogenomics, point-of-care testing (POCT), pharmacist prescribing authority, community pharmacy management, immunization services, opioid epidemic policies, Prescription Drug Monitoring Programs (PDMPs), Michigan Automated Prescription System (MAPS), abuse-deterrent opioid formulations, naloxone access laws, Good Samaritan overdose laws, supervised injection sites, needle exchange programs, COVID-19 virology, SARS-CoV-2 transmission, PCR testing, antigen testing, serologic testing, Clinical Laboratory Improvement Amendments (CLIA), coronavirus structure, vaccine-related concepts, long-term care pharmacy, geriatric pharmacotherapy, medication optimization, polypharmacy, pharmacist-led interventions, medication safety, healthcare policy, and pharmaceutical care for older adults. The study guide integrates pharmacy law, public health, pharmacoeconomics, clinical research, and patient-centered pharmaceutical care to prepare students for advanced pharmacy coursework and professional practice. This study guide is ideal for PHAR 515 students, Doctor of Pharmacy (PharmD) students, pharmacy technician students, pharmaceutical sciences students, clinical pharmacy students, community pharmacy students, ambulatory care pharmacy students, healthcare policy students, pharmacoeconomics students, pharmacy residents, and learners preparing for pharmacy school examinations, NAPLEX, MPJE, and professional competency assessments. The content aligns with leading pharmacy education references and evidence-based professional guidelines, including: DiPiro, J. T., Yee, G. C., Posey, L. M., Haines, S. T., Nolin, T. D., & Ellingrod, V. Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill. Remington. The Science and Practice of Pharmacy. Pharmaceutical Press. Rascati, K. L. Essentials of Pharmacoeconomics. Lippincott Williams & Wilkins. U.S. Food and Drug Administration (FDA). Guidance for Industry: Investigational New Drug Applications, New Drug Applications, and Postmarketing Safety Reporting. U.S. Food and Drug Administration (FDA). FAERS (FDA Adverse Event Reporting System) and MedWatch Safety Information and Adverse Event Reporting Program. Centers for Disease Control and Prevention (CDC). COVID-19 Clinical Guidance and Opioid Overdose Prevention Resources. American Pharmacists Association (APhA). Pharmacy Practice Standards and Immunization Delivery Guidelines. American Society of Health-System Pharmacists (ASHP). Best Practices and Professional Practice Standards. Accreditation Council for Pharmacy Education (ACPE). Standards for the Doctor of Pharmacy Program. Relevant students: PHAR 515 Students, Doctor of Pharmacy (PharmD) Students, Clinical Pharmacy Students, Community Pharmacy Students, Pharmaceutical Sciences Students, Pharmacy Technician Students, Ambulatory Care Pharmacy Students, Healthcare Policy Students, Pharmacoeconomics Students, Pharmacy Residents, NAPLEX Candidates, MPJE Candidates, Healthcare Professionals. Keywords PHAR 515, PHAR 515 Final Exam, Pharmacoeconomics, Patient Reported Outcomes, PROs, Health Related Quality of Life, HRQOL, QALY, Cost Effectiveness Analysis, Health Outcomes Research, Drug Approval Process, FDA Drug Approval, IND, NDA, ANDA, Clinical Trials, Randomized Controlled Trials, RCT, Placebo, Randomization, Double Blind Study, FAERS, MedWatch, Bioavailability, Bioequivalence, Generic Drugs, Pharmacy Law, Professionalism, HIPAA, Protected Health Information, PHI, Community Pharmacy, Telepharmacy, Medication Therapy Management, MTM, Collaborative Practice Agreement, Pharmacogenomics, Point of Care Testing, Opioid Epidemic, PDMP, MAPS, Naloxone, Good Samaritan Law, COVID-19, SARS-CoV-2, PCR Testing, Antigen Testing, Long Term Care Pharmacy, Geriatric Pharmacy, Polypharmacy, NAPLEX Review, Pharmacy Exam Questions, Verified Answers, Study Guide

Show more Read less
Institution
Phar 515
Course
Phar 515

Content preview

Phar 515 Final 2026 Exam
Questions and Answers |
Already Graded A+



PROs and cost-effectiveness analysis


health outcomes classifications - ANSWER ✔✔-clinical outcomes


-clinical reported outcomes

-economic outcomes

-patient reported/humanistic outcomes


clinical outcomes examples - ANSWER ✔✔-lab results


-x ray results

,clinical reported outcomes examples - ANSWER ✔✔-MD palpation

during physical examination

-RN reporting a vomiting episode


economic outcomes examples - ANSWER ✔✔-total costs spent on

cancer treatment

-work days lost due to illness


patient reported outcome examples - ANSWER ✔✔-patient reported

symptoms/functions

-health related quality of life


why are PROs important? - ANSWER ✔✔-some treatment effects are

only known to the patient (pain, smoking cessation, anxiety)

-traditional assessments made by clinicians or lab values are not

sufficient to evaluate patient preferences

-patient's perspective may not coincide with objective assessments


how are PROs used? - ANSWER ✔✔they are used to measure


-drug effectiveness

-drug safety

-quality

,-and help with decision making


2 HRQOL instruments - ANSWER ✔✔-general/generic instruments


-disease or condition specific instruments


general or generic HRQOL instruments - ANSWER ✔✔-broadly

applicable to general population

-summarize range of basic domains

-Ex) SF-36, SF-12, SF-8


disease or condition specific HRQOL instruments - ANSWER ✔✔-

relevant to patients with specific disease or condition

-more sensitive to specific disease effects

-Example: asthma quality of life questionnaire (AQLQ)


health state utility - ANSWER ✔✔measures the patient preference of

a specific health state or health outcomes, higher utility scores are

associated with more desirable health states


how are health state utility and HRQOL different? - ANSWER ✔✔-for

HRQOL, the scoring mechanisms differ by the instrument




3
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED

, -health safety utility is always scored on a scale of 0 (death) to 1 (perfect

health)


QALY - ANSWER ✔✔-quality adjusted life years


-capture both quality and quantity of life simultaneously

-QALY = additional life years gained x utility of those life years


four different categories of costs - ANSWER ✔✔-direct medical costs


-direct nonmedical costs

-indirect costs

-intangible costs


direct medical mosts - ANSWER ✔✔-medically related inputs used

directly to provide the treatment

-Ex: drug costs, diagnostic tests, physician costs


direct nonmedical costs - ANSWER ✔✔-costs directly associated with

treatment but not medical in nature

-Ex: cost of traveling to the doctor's office


indirect costs - ANSWER ✔✔-costs tha tresult from the loss of

productivity during the illness

-Ex: cost of missing workdays (wage x missed time)

Written for

Institution
Phar 515
Course
Phar 515

Document information

Uploaded on
July 1, 2026
Number of pages
33
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

$18.99
Get access to the full document:

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
JOSHCLAY West Governors University
View profile
Follow You need to be logged in order to follow users or courses
Sold
360
Member since
2 year
Number of followers
15
Documents
19882
Last sold
1 day ago
JOSHCLAY

JOSHCLAY EXAM HUB, WELCOME ALL, HERE YOU WILL FIND ALL DOCUMENTS & PACKAGE DEAL YOU NEED FOR YOUR SCHOOL WORK OFFERED BY SELLER JOSHCLAY

3.5

80 reviews

5
31
4
12
3
16
2
8
1
13

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions